Perrigo Scopolamine Transdermal System Recall: Defective Delivery System
Perrigo recalls specific Scopolamine Transdermal Therapeutic Systems (1 mg/3 days) due to defective delivery system. Affected products include 4-count and 10-count units with certain lot numbers. No remedy is stated in the recall notice.
“Perrigo Scopolamine Transdermal System Recall: Defective Delivery System.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40554-perrigo-scopolamine-transdermal-system-recall-defective-delivery-system. Based on FDA recall #D-0816-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0816-2018%22&limit=1).
The FDA announced on May 11, 2018, that L. Perrigo Company is recalling Scopolamine Transdermal Therapeutic Systems due to a defective delivery system. The recall affects 569,520 cartons distributed nationwide.
How to tell if you have it
Brand: Perrigo
Product: Scopolamine Transdermal Therapeutic System, 1 mg/3 days
The product has a defective delivery system. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show L. Perrigo Company has 7 other recalls on record since December 28, 2016. Other recent recalls of similar products include Bell Pharmaceuticals Clinere Carbamide Peroxide Recall (June 25, 2026), Golden State Medical Recalls Prasugrel HCl 10mg Tablets (August 21, 2026), and Teva Clonidine Transdermal System Recall (March 19, 2026).
How to tell if you have this one
Check the product label for the quantity (4-count or 10-count) and the lot number listed in the recall notice. The product is prescription-only and distributed by Perrigo.
Brand
Perrigo
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the product quantity (4-count or 10-count) and lot number to determine if it is recalled.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide in the U.S.A.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.4 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0816-2018 (May 11, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0816-2018 to see it in context.
Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.